Q4 2021 13F Holders as of 12/31/2021
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
44.9M
-
Number of holders
-
261
-
Total 13F shares, excl. options
-
50.5M
-
Shares change
-
+1.31M
-
Total reported value, excl. options
-
$3.04B
-
Value change
-
+$80.6M
-
Put/Call ratio
-
3.06
-
Number of buys
-
137
-
Number of sells
-
-103
-
Price
-
$60.17
Significant Holders of Pacira BioSciences, Inc. - Common Stock, par value $0.001 per share (PCRX) as of Q4 2021
297 filings reported holding PCRX - Pacira BioSciences, Inc. - Common Stock, par value $0.001 per share as of Q4 2021.
Pacira BioSciences, Inc. - Common Stock, par value $0.001 per share (PCRX) has 261 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 50.5M shares
.
Largest 10 shareholders include BlackRock Inc. (6.82M shares), VANGUARD GROUP INC (4.67M shares), MACQUARIE GROUP LTD (3.78M shares), BAILLIE GIFFORD & CO (2.36M shares), Spyglass Capital Management LLC (2.1M shares), RENAISSANCE TECHNOLOGIES LLC (1.85M shares), PAULSON & CO. INC. (1.71M shares), STATE STREET CORP (1.53M shares), ARMISTICE CAPITAL, LLC (1.31M shares), and LOOMIS SAYLES & CO L P (1.19M shares).
This table shows the top 261 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.